MV4-11 cells present a FLT3-ITD mutation that renders a hyper-active and hyper-phosphorylated form of the FLT3 tyrosine kinase, which in turns phosphorylates STAT5B at Try699 to drive leukaemia progression [28, 53]. This evidence concerns the gene STAT5B and leukemia.